Abstract
Diabetic mellitus is a metabolic disease primarily defined by the level of hyperglycemia that gives rise to complications such as retinopathy, nephropathy, and neuropathy. Reactive oxygen species (ROS) generation and impaired antioxidant defense systems have been implicated in the development of diabetes mellitus. Palmatine is a protoberberine alkaloid has shown potential for the treatment of hypertension, inflammation, and liver-related diseases. Our study aimed at evaluating the blood plasma glucose lowering, in vivo antioxidant, liver and profile activity of palmatine in an STZ-induced diabetic rat model. Streptozotocin (STZ) was administered by intraperitoneal injection to induce diabetes in Sprague dawley rats. A week later rats with plasma glucose level of 11mmol/L or 200mg/dL and above were orally administered with palmatine (2mg/kg) for 90 days. The blood glucose level and body weight of the rats were measured weekly. After 90 days of treatment, the rat blood was withdrawn via cardiac puncture and liver and pancreas were harvested after they were sacrificed by cervical dislocation. Palmatine significantly decreased the blood plasma glucose and lipid peroxidation compared to the positive control Tolbutamide. While the activity of the antioxidant defense system and blood parameters were normalised. Palmatine significantly (P<0.0001) reduced the blood plasma glucose level, increased the weight of the rats in palmatine treated group, plasma glucose parameters and in vivo antioxidant activity In conclusion plamatine improved blood glucose levels and reduced the oxidative stress. Therefore it may be considered in the treatment of diabetes.
Keywords: Antioxidant, diabetes, histology, palmatine, plasma lowering, streptozotocin, type 2 diabetes.
Current Bioactive Compounds
Title:Plasma Glucose Lowering Activity of Palmatine and its Effect on Liver, Kidney and Antioxidant Enzymes Parameters in STZ Induced Diabetic Rat Model
Volume: 11 Issue: 4
Author(s): Sophia Ogechi Ekeuku, Patrick Nwabueze Okechukwu, Gabriel Akyirem Akowoah, Teo Swee Sen, Stepfanie Namatama Siyumbwa and Gabriele Ruth Anisah Froemming
Affiliation:
Keywords: Antioxidant, diabetes, histology, palmatine, plasma lowering, streptozotocin, type 2 diabetes.
Abstract: Diabetic mellitus is a metabolic disease primarily defined by the level of hyperglycemia that gives rise to complications such as retinopathy, nephropathy, and neuropathy. Reactive oxygen species (ROS) generation and impaired antioxidant defense systems have been implicated in the development of diabetes mellitus. Palmatine is a protoberberine alkaloid has shown potential for the treatment of hypertension, inflammation, and liver-related diseases. Our study aimed at evaluating the blood plasma glucose lowering, in vivo antioxidant, liver and profile activity of palmatine in an STZ-induced diabetic rat model. Streptozotocin (STZ) was administered by intraperitoneal injection to induce diabetes in Sprague dawley rats. A week later rats with plasma glucose level of 11mmol/L or 200mg/dL and above were orally administered with palmatine (2mg/kg) for 90 days. The blood glucose level and body weight of the rats were measured weekly. After 90 days of treatment, the rat blood was withdrawn via cardiac puncture and liver and pancreas were harvested after they were sacrificed by cervical dislocation. Palmatine significantly decreased the blood plasma glucose and lipid peroxidation compared to the positive control Tolbutamide. While the activity of the antioxidant defense system and blood parameters were normalised. Palmatine significantly (P<0.0001) reduced the blood plasma glucose level, increased the weight of the rats in palmatine treated group, plasma glucose parameters and in vivo antioxidant activity In conclusion plamatine improved blood glucose levels and reduced the oxidative stress. Therefore it may be considered in the treatment of diabetes.
Export Options
About this article
Cite this article as:
Ogechi Ekeuku Sophia, Nwabueze Okechukwu Patrick, Akyirem Akowoah Gabriel, Swee Sen Teo, Namatama Siyumbwa Stepfanie and Anisah Froemming Gabriele Ruth, Plasma Glucose Lowering Activity of Palmatine and its Effect on Liver, Kidney and Antioxidant Enzymes Parameters in STZ Induced Diabetic Rat Model, Current Bioactive Compounds 2015; 11 (4) . https://dx.doi.org/10.2174/1573407212666151105185802
DOI https://dx.doi.org/10.2174/1573407212666151105185802 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Partial Failure of Membrane Protein Turnover May Cause Alzheimers Disease: A New Hypothesis
Current Alzheimer Research Plasma Non-cholesterol Sterols as Markers of Cholesterol Synthesis and Intestinal Absorption: A Critical Review
Current Pharmaceutical Design Carbopol 934-P Loaded with Vildagliptin for Diabetic Delivery: In Vitro and In Vivo Evaluation of Nanoparticles
Current Nanoscience Vitamin D Metabolites and/or Analogs: Which D for Which Patient?
Current Vascular Pharmacology Development of a Fermentation Process for Utilization of Emblica Officinalis Gaertn (Amla) Candy Waste for Production of Natural Vinegar
Current Nutrition & Food Science Nutrition Transition and Obesity Among Teenagers and Young Adults in South Asia
Current Diabetes Reviews In Silico Computations of Selective Phytochemicals as Potential Inhibitors Against Major Biological Targets of Diabetes Mellitus
Current Computer-Aided Drug Design EarlyVascularAgeing and Hypertension -A New Model for Understanding Cardiovascular Risk
Current Hypertension Reviews Effects of Coenzyme Q10 Supplementation on Serum Adiponectin Levels: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Current Drug Therapy Unique Coronary Artery Disease Differences in Women as Related to Revascularization
Current Medicinal Chemistry The Mechanism of Dead-in-Bed Syndrome and Other Sudden Unexplained Nocturnal Deaths
Current Diabetes Reviews Impact of Mitochondrial Toxicity of HIV-1 Antiretroviral Drugs on Lipodystrophy and Metabolic Dysregulation
Current Pharmaceutical Design Promising Diabetes Therapy Based on the Molecular Mechanism for Glucose Toxicity: Usefulness of SGLT2 Inhibitors as well as Incretin-Related Drugs
Current Medicinal Chemistry Hypertensive Heart Disease and the Role of Aldosterone Antagonists
Current Hypertension Reviews Synthesis and Antimicrobial Activity of Adamantyl Substituted Pyridoxine Derivatives
Letters in Drug Design & Discovery Laboratory Monitoring of Hematological and Hepatic Parameters in Ambulatory Patients Receiving Alpha-Methyldopa in a Nigerian Tertiary Care Setting
Current Drug Safety Biological Ageing, Inflammation and Nutrition: How Might They Impact on Systemic Sclerosis?
Current Aging Science Formulation and Characterisation of Glimepiride Loaded Biodegradable Nanoparticles for the Management of Type 2 Diabetes Mellitus
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Therapeutic Approaches to Alzheimer’s Type of Dementia: A Focus on FGF21 Mediated Neuroprotection
Current Pharmaceutical Design A Knock-Down Cell-Based Study for the Functional Analysis of Chloride Intracellular Channel 1 (CLIC1): Integrated Proteomics and Microarray Study
Protein & Peptide Letters